Relates to adding W-18 to the schedule of controlled substances

Introduced

In Committee

Floor

Crossed Over

Passed

Enacted

Overview Bill text 1 History 2 Sponsors

Adds W-18(4-chloro-N-{1-{2-(4-nitrophenyl)ethyl} 2piperidinylidene}benzenesulfonamide) to the schedule of controlled substances.

Chamber: Senate
Introduced: Feb 5, 2025
Last action: Jan 7, 2026 — REFERRED TO HEALTH
Session: 2025-2026
Momentum: 27 · Low

PASSAGE PROBABILITY

1% Unlikely

Why this number

Stage base In Committee — base rate 5%, measured from NY's completed sessions
Momentum -5 27/100 from the pace of recorded action
Time since last action -22 285 days quiet

A transparent scoring model over stage, momentum, recency, sponsorship and recorded votes — not a trained predictor. Treat it as a way to rank attention, not as a forecast.